Clinical Trials Logo

Filter by:
NCT ID: NCT05511662 Not yet recruiting - Atrial Fibrillation Clinical Trials

Patient-reported Outcome Follow-up Based on the Northern Shanghai Community Chronic Disease Management System

Start date: September 1, 2022
Phase:
Study type: Observational

Influence of patient-reported outcome follow-up based on the northern Shanghai community chronic disease management system on the follow-up compliance and satisfaction of patients with atrial fibrillation after cryoablation.

NCT ID: NCT05511649 Completed - Clinical trials for Acute Myocardial Infarction

New-Onset Atrial Fibrillation Complicating Acute Myocardial Infarction in China

NOAFCAMI-China
Start date: March 1, 2023
Phase:
Study type: Observational

To investigate the prognostic impacts of the atrial fibrillation burden (AFb) in acute myocardial infarction (AMI) patients who developed paroxysmal new-onset atrial fibrillation (NOAF) during the index AMI hospitalization.

NCT ID: NCT05511623 Recruiting - Cervical Cancer Clinical Trials

Tislelizumab Combined With Concurrent Chemoradiotherapy as First-line Treatment for Stage IIIC2 Cervical Cancer

Start date: September 1, 2022
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy and safety of tislelizumab combined with concurrent chemoradiotherapy in first-line treatment of stage IIIC2 cervical cancer.

NCT ID: NCT05511506 Completed - Cataract Clinical Trials

Cytokines in Femtosecond Laser-assisted Cataract Surgery

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

The investigators performed the current study to compare: 1) the pain scores by Visual Analogue Scale; 2) the cytokines concentrations in aqueous humor by human cytokine antibody array; 3) the prostaglandin E2 (PGE2) concentrations by enzyme linked immunosorbent assay (ELISA); 4) the pupil behaviors by Image J between first-eye and second-eye in bilateral cataract patients undergoing sequential femtosecond laser-assisted cataract surgery (FLACS). To our knowledge, this is the first intraindividual study investigating contralateral effect in FLACS. The findings from the current study may broaden our understanding on the mechanism of sympathetic reaction, help to improve clinical performances, and provide strong clinical guidance for cataract surgeons.

NCT ID: NCT05511441 Recruiting - Surgery Clinical Trials

Routine Minimally Invasive Thoracic Surgery Without Aspirin Withdraw

Start date: June 1, 2020
Phase: N/A
Study type: Interventional

Surgeons are increasingly confronted by patients on long-term low-dose acetylsalicylic acid (ASA). However, the perioperative management of these patients undergo non-cardiac surgery has not yet been clear. This single- arm study was to evaluate the safety of continuous use of ASA in the perioperative period in routine minimally thoracic surgery.

NCT ID: NCT05511051 Recruiting - Colorectal Cancer Clinical Trials

A Prospective Multi-centered Randomized Controlled Trial on Fruquintinib in Combination With HAIC in the Treatment of Liver Metastatic Colorectal Cancer After Failure of Second-line Systematic Therapy

Start date: February 1, 2022
Phase: Phase 2
Study type: Interventional

The current study is to investigate the safety and efficacy of fruquintinib combined with HAIC in patients with advanced colorectal liver metastases who have failed second-line systemic standard treatment, in order to provide more survival opportunities for the second progression of advanced colorectal liver metastases.

NCT ID: NCT05510986 Not yet recruiting - Effect of Drug Clinical Trials

The Effect of Oxycodone Hydrochloride on CRBD After TURBT Under General Anesthesia

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effect of Oxycodone Hydrochloride on catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor after general anesthesia.

NCT ID: NCT05510830 Not yet recruiting - Cervical Cancer Clinical Trials

Diagnostic Cervical Conization for Persistent Infection or Integration of HPV

Start date: October 2022
Phase: N/A
Study type: Interventional

For the patients with cervical persistent infection or integration of HPV, we has designed a program to perform cervical conization for certain patients to earlier and better diagnose and cure the diseases of HPV infection and related cervical intraepithelial neoplasia/cancer.

NCT ID: NCT05510700 Recruiting - Breast Neoplasms Clinical Trials

Efficacy of Acupuncture Treatment for Breast Cancer-associated Insomnia

Start date: October 20, 2022
Phase: N/A
Study type: Interventional

Through a scientific and standardized multicenter, randomized, and controlled study method, the investigators evaluated the clinical efficacy and safety of acupuncture in the treatment of breast cancer-related insomnia, with a view to providing a reliable theoretical basis for the treatment of breast cancer-related insomnia with acupuncture.

NCT ID: NCT05510544 Recruiting - Lymphoma Clinical Trials

Plerixafor for Poorly Mobilized Lymphoma

Start date: December 19, 2022
Phase: Phase 4
Study type: Interventional

Autologous hematopoietic stem cell transplantation is one of the effective means of lymphoma treatment, but patients who receive transplantation in the absence of sufficient stem cell numbers have a delay in stem cell engraftment and a markedly increased risk of infection and emergence. Plerixafor injection is a strong and specific antagonist of CXCR4. It can rapidly mobilize stem cells from bone marrow into peripheral blood circulation by blocking the combination of SDF1 and CXCR4. Studies have shown that the simultaneous use of plerixafor injection and G-CSF can collect more hematopoietic stem cells in a certain period of time than cancer patients who use G-CSF alone. This multicenter, open-label, single-arm study was designed to evaluate the efficacy and safety of plerixafor injection for hematopoietic stem cell mobilization in poorly mobilized lymphoma patients.